Verano Holdings Partners with Grow Sciences to Expand Cannabis Offerings in Illinois

The latest update is out from Verano Holdings ( (TSE:VRNO) ).

Verano Holdings has announced an exclusive partnership with Arizona-based Grow Sciences to introduce a range of premium cannabis products to the Illinois market. This collaboration will see Grow Sciences’ award-winning flower, pre-rolls, and solventless extracts sold at Zen Leaf dispensaries, enhancing Verano’s product offerings and strengthening its market position in Illinois.

The most recent analyst rating on (TSE:VRNO) stock is a Buy with a C$4.00 price target. To see the full list of analyst forecasts on Verano Holdings stock, see the TSE:VRNO Stock Forecast page.

Spark’s Take on TSE:VRNO Stock

According to Spark, TipRanks’ AI Analyst, TSE:VRNO is a Neutral.

The overall stock score is primarily impacted by the financial performance challenges, including declining revenues and negative profitability. Technical analysis indicates overbought conditions, further pressurizing the stock’s outlook. Despite strategic expansion efforts reflected in corporate events, the valuation remains unattractive due to a negative P/E ratio and lack of dividend yield.

To see Spark’s full report on TSE:VRNO stock, click here.

More about Verano Holdings

Verano Holdings Corp. is a leading multi-state cannabis company known for its operations across various states. The company focuses on offering a wide range of cannabis products, including flower, extracts, and edibles, through its Zen Leaf dispensaries.

Technical Sentiment Signal: Sell

Current Market Cap: C$2.17B

Learn more about VRNO stock on TipRanks’ Stock Analysis page.